2022 LIVER Symposium
The NCSCG Board and Meeting Planning Committee are proud to announce the 7th Annual NCSCG hybrid Liver Symposium, being held January 29, 2022, both online and in-person at the InterContinental San Francisco Hotel in San Francisco, CA!
The symposium will provide a unique opportunity to receive a comprehensive update in chronic liver disease from nationally renowned faculty. The educational lectures at this symposium will focus on important advances presented at the annual American Association for the Study of Liver Disease (AASLD) Meeting and/or in recent publications. You will also have ample opportunity to interact with colleagues, our expert faculty members, and industry representatives.
Click on the link above for complete conference and registration information. Please feel free to contact the NCSCG with any questions or comments by sending an email to firstname.lastname@example.org.
The 2022 NCSCG Liver Planning Committee
Edward W. Holt, MD; NCSCG President
Allison Kwong, MD; Board Member
Marina Roytman, MD, FACP; Board Member
Sandip Suprai, DNP, RN, FNP-BC; Board Member
This activity has been designed to meet the educational needs of physicians, physician assistants and nurse practitioners involved in the care of patients with chronic liver disease (CLD).
Statement of Need
The goal of this program is to provide important clinical and scientific data on the management of chronic liver disease (CLD).
Upon completion of this symposium, participants should be better able to:
Describe current guidelines for the treatment and management of patients with liver disease
Optimize treatment results for patients with liver disease, through utilizing new therapies
Identify new advances presented at 2021 AASLD and assess their potential impact on clinical practice
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of the Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Northern California Society for Clinical Gastroenterology. RMCHCS is accredited by NMMS to provide continuing medical education for physicians.
RMCHCS designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 6.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Participants will be able to locate MOC information on this ACCME website
This activity is supported by an educational grant from Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A, Inc.